{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:12:01Z","timestamp":1775041921479,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) is a common metabolic disorder. Type 1 diabetes (T1D) can cause hepatopathies as the liver is the primary organ of glucose metabolism. This study sought to investigate the possible protective effects of trimetazidine (TMZ) on T1D liver disease and the mechanism underlying these effects through alleviation of endoplasmic reticulum stress-mediated NLRP3 inflammasome activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Twenty-four Sprague\u2013Dawley rats were equally divided into four groups: control, TMZ, T1D, and T1D\u2009+\u2009TMZ groups. After killing, blood samples were collected to assess glucose, insulin, ALT, AST, and IL-1\u03b2. Livers were harvested and divided into left and right lobes. The left lobe was further divided into part preserved for IRE1, CHOP, and NLRP3 mRNA expression and the other part homogenized for colorimetric measurement of malondialdehyde (MDA). The right lobe was preserved for histopathological assessment and immunohistochemical assessments of NLRP3 and caspase-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Trimetazidine ameliorated T1D-induced liver damage. TMZ significantly reduced MDA levels and the ER stress markers inositol requiring enzyme (IRE1) and C\/EBP homologous protein (CHOP), leading to suppression of NLRP3 inflammasome activation, IL-1\u03b2, and caspase-1 dependent pyroptosis. Additionally, TMZ improved hepatic histological architecture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results demonstrate a hepatoprotective role for TMZ in T1D-induced liver injury, potentially mediated through suppression of ER stress, inflammation, and caspase-1-dependent pyroptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-026-03949-1","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:48:31Z","timestamp":1771670911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trimetazidine is associated with suppression of endoplasmic reticulum stress-mediated NLRP3 inflammasome activation in type 1 diabetes-induced liver damage in rats"],"prefix":"10.1186","volume":"31","author":[{"given":"Eman A. E.","family":"Farrag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha O.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Shouman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally M.","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Abd El-kader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"3949_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37678-w","volume":"13","author":"EAE Farrag","year":"2023","unstructured":"Farrag EAE, Hammad MO, Safwat SM, Hamed S, Hellal D. Artemisinin attenuates type 2 diabetic cardiomyopathy in rats through modulation of AGE-RAGE\/HMGB-1 signaling pathway. Sci Rep. 2023;13:11043. https:\/\/doi.org\/10.1038\/s41598-023-37678-w.","journal-title":"Sci Rep"},{"key":"3949_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00935-5","volume":"14","author":"AM Mahfoz","year":"2022","unstructured":"Mahfoz AM, Gawish AY. Insight into the hepatoprotective, hypolipidemic, and antidiabetic impacts of aliskiren in streptozotocin-induced diabetic liver disease in mice. Diabetol Metab Syndr. 2022;14:163. https:\/\/doi.org\/10.1186\/s13098-022-00935-5.","journal-title":"Diabetol Metab Syndr"},{"key":"3949_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biopha.2018.05.120","volume":"105","author":"V Rodr\u00edguez","year":"2018","unstructured":"Rodr\u00edguez V, Plavnik L, de Tolosa Talamoni N. Naringin attenuates liver damage in streptozotocin-induced diabetic rats. Biomed Pharmacother. 2018;105:95\u2013102. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.120.","journal-title":"Biomed Pharmacother"},{"key":"3949_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12902-023-01535-8","volume":"24","author":"Z Karimi","year":"2024","unstructured":"Karimi Z, Daryabor G, Masjedi F. Effects of conditioned media derived from human Wharton\u2019s jelly mesenchymal stem cells on diabetic nephropathy and hepatopathy via modulating TGF-\u03b2 and apelin signaling pathways in male rats. BMC Endocr Disord. 2024;24:6. https:\/\/doi.org\/10.1186\/s12902-023-01535-8.","journal-title":"BMC Endocr Disord"},{"key":"3949_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/CM9.0000000000000583","volume":"133","author":"Z-H Cao","year":"2020","unstructured":"Cao Z-H, Wu Z, Hu C, Zhang M, Wang W-Z, Hu X-B. Endoplasmic reticulum stress and destruction of pancreatic \u03b2 cells in type 1 diabetes. Chin Med J (Engl). 2020;133:68\u201373. https:\/\/doi.org\/10.1097\/CM9.0000000000000583.","journal-title":"Chin Med J (Engl)"},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00125-015-3669-6","volume":"58","author":"F Brozzi","year":"2015","unstructured":"Brozzi F, Nardelli TR, Lopes M, Millard I, Barthson J, Igoillo-Esteve M, et al. Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms. Diabetologia. 2015;58:2307\u201316. https:\/\/doi.org\/10.1007\/s00125-015-3669-6.","journal-title":"Diabetologia"},{"key":"3949_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/SHK.0000000000002011","volume":"58","author":"Y Zhan","year":"2022","unstructured":"Zhan Y, Chen Z, Qiu Y, Deng Q, Huang W, Wen S, et al. DEXMEDETOMIDINE prevents PDIA3 decrease by activating \u03b12-adrenergic receptor to alleviate intestinal I\/R in mice. Shock. 2022;58:556\u201364. https:\/\/doi.org\/10.1097\/SHK.0000000000002011.","journal-title":"Shock"},{"key":"3949_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051219","volume":"9","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Tong Z, Jiang S, Zheng W, Zhao J, Zhou X. The roles of endoplasmic reticulum in NLRP3 inflammasome activation. Cells. 2020;9:1219. https:\/\/doi.org\/10.3390\/cells9051219.","journal-title":"Cells"},{"key":"3949_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome. Mol Cell. 2002;10:417\u201326. https:\/\/doi.org\/10.1016\/S1097-2765(02)00599-3.","journal-title":"Mol Cell"},{"key":"3949_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1247","author":"WC Chong","year":"2021","unstructured":"Chong WC, Shastri MD, Peterson GM, Patel RP, Pathinayake PS, Dua K, et al. The complex interplay between endoplasmic reticulum stress and the NLRP3 inflammasome: a potential therapeutic target for inflammatory disorders. Clin Transl Immunol. 2021. https:\/\/doi.org\/10.1002\/cti2.1247.","journal-title":"Clin Transl Immunol"},{"key":"3949_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biom9120850","volume":"9","author":"S Ding","year":"2019","unstructured":"Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes. Biomolecules. 2019;9:850. https:\/\/doi.org\/10.3390\/biom9120850.","journal-title":"Biomolecules"},{"key":"3949_CR12","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","volume":"40","author":"Y Xue","year":"2019","unstructured":"Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol. 2019;40:1035\u201352. https:\/\/doi.org\/10.1016\/j.it.2019.09.005.","journal-title":"Trends Immunol"},{"key":"3949_CR13","unstructured":"Jiang DZX. Relationship between the expression of NLRP3 inflammasome in renal biopsy and renal damage of diabetic nephropathy. J Trop Med. 2021;99\u2013102."},{"key":"3949_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1068-5","volume":"14","author":"L Zhang","year":"2016","unstructured":"Zhang L, Ding W, Wang Z, Tang M, Wang F, Li Y, et al. Erratum to: early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy. J Transl Med. 2016;14:309. https:\/\/doi.org\/10.1186\/s12967-016-1068-5.","journal-title":"J Transl Med"},{"key":"3949_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4149\/BLL_2015_024","volume":"116","author":"A Tanoglu","year":"2015","unstructured":"Tanoglu A, Yamanel L, Inal V, Ocal R, Comert B, Bilgi C. Appreciation of trimetazidine treatment in experimental sepsis rat model. Bratisl Med J. 2015;116:124\u20137. https:\/\/doi.org\/10.4149\/BLL_2015_024.","journal-title":"Bratisl Med J"},{"key":"3949_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jphs.2019.01.016","volume":"139","author":"S-G Tang","year":"2019","unstructured":"Tang S-G, Liu X-Y, Wang S-P, Wang H-H, Jovanovi\u0107 A, Tan W. Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2\/TRPC3-induced oxidative stress. J Pharmacol Sci. 2019;139:311\u20138. https:\/\/doi.org\/10.1016\/j.jphs.2019.01.016.","journal-title":"J Pharmacol Sci"},{"key":"3949_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00648-0","volume":"7","author":"L Wang","year":"2021","unstructured":"Wang L, Jiao X-F, Wu C, Li X-Q, Sun H-X, Shen X-Y, et al. Trimetazidine attenuates dexamethasone-induced muscle atrophy via inhibiting NLRP3\/GSDMD pathway-mediated pyroptosis. Cell Death Discov. 2021;7:251. https:\/\/doi.org\/10.1038\/s41420-021-00648-0.","journal-title":"Cell Death Discov"},{"issue":"3","key":"3949_CR18","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.3892\/mmr.2020.11309","volume":"22","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li C, Li X, Wu C, Zhou H, Lu S, et al. Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway. Mol Med Rep. 2020;22(3):2174\u201382.","journal-title":"Mol Med Rep"},{"issue":"10","key":"3949_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102299","volume":"12","author":"S Ciftel","year":"2024","unstructured":"Ciftel S, Mercantepe T, Aktepe R, Pinarbas E, Ozden Z, Yilmaz A, et al. Protective effects of Trimetazidine and Dexmedetomidine on liver injury in a mesenteric artery ischemia\u2013reperfusion rat model via endoplasmic reticulum stress. Biomedicines. 2024;12(10):2299.20.","journal-title":"Biomedicines"},{"key":"3949_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/and.12780","volume":"49","author":"MF Ozcan","year":"2017","unstructured":"Ozcan MF, Hekimoglu ER, Ener K, Namuslu M, Altintas R, Celik HT, et al. Trimetazidine has protective effects on spermatogenesis in a streptozotocin-induced diabetic rat model. Andrologia. 2017;49:e12780. https:\/\/doi.org\/10.1111\/and.12780.","journal-title":"Andrologia"},{"key":"3949_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","volume":"28","author":"S Reitman","year":"1957","unstructured":"Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56\u201363. https:\/\/doi.org\/10.1093\/ajcp\/28.1.56.","journal-title":"Am J Clin Pathol"},{"key":"3949_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351\u20138. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3.","journal-title":"Anal Biochem"},{"key":"3949_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"3949_CR24","unstructured":"Bancroft JD, G.M. Theory and practice of the histological techniques. Churchill Livingstone, London; 2002."},{"key":"3949_CR25","unstructured":"Chen Y, YQ, XC-B. A convenient method for quantifying collagen fibers in atherosclerotic lesions by ImageJ software. Int J Clin Exp Med. 2017;10:14927\u201335."},{"key":"3949_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8215842","volume":"2022","author":"B Zhang","year":"2022","unstructured":"Zhang B, Sun C, Liu Y, Bai F, Tu T, Liu Q. Exosomal miR-27b-3p derived from hypoxic cardiac microvascular endothelial cells alleviates rat myocardial ischemia\/reperfusion injury through inhibiting oxidative stress-induced pyroptosis via Foxo1\/GSDMD signaling. Oxid Med Cell Longev. 2022;2022:1\u201319. https:\/\/doi.org\/10.1155\/2022\/8215842.","journal-title":"Oxid Med Cell Longev"},{"key":"3949_CR27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.omtn.2019.08.028","volume":"18","author":"Y Ying","year":"2019","unstructured":"Ying Y, Mao Y, Yao M. NLRP3 inflammasome activation by MicroRNA-495 promoter methylation may contribute to the progression of acute lung injury. Mol Ther Nucleic Acids. 2019;18:801\u201314. https:\/\/doi.org\/10.1016\/j.omtn.2019.08.028.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3949_CR28","first-page":"274","volume":"22","author":"A Ghasemi","year":"2023","unstructured":"Ghasemi A, Jeddi S. Streptozotocin as a tool for induction of rat models of diabetes: a practical guide. EXCLI J. 2023;22:274.","journal-title":"EXCLI J"},{"key":"3949_CR29","doi-asserted-by":"publisher","unstructured":"Omran E, Alzahrani AR, Ezzat SF, Ellithy G, Tarek M, Khairy E, Ghit MM, Elgeushy A, Ibrahim Al-Hazani TM, Aziz Ibrahim IA, Falemban AH, Bamagous GA, Elhawary NA, Jaremko M, Saied EM, Mohamed DI. Deciphering the therapeutic potential of trimetazidine in rheumatoid arthritis via targeting mi-RNA128a, TLR4 signaling pathway, and adenosine-induced FADD-microvesicular shedding: In vivo and in silico study. Front Pharmacol. 2024;15. https:\/\/doi.org\/10.3389\/fphar.2024.1406939","DOI":"10.3389\/fphar.2024.1406939"},{"key":"3949_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1464-5491.2005.01499.x","volume":"22","author":"DA Rees","year":"2005","unstructured":"Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med. 2005;22:359\u201370. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01499.x.","journal-title":"Diabet Med"},{"key":"3949_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/2251-6581-12-60","volume":"12","author":"CO Eleazu","year":"2013","unstructured":"Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord. 2013;12:60. https:\/\/doi.org\/10.1186\/2251-6581-12-60.","journal-title":"J Diabetes Metab Disord"},{"key":"3949_CR32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3892\/etm.2015.2305","volume":"9","author":"AJ Fatani","year":"2015","unstructured":"Fatani AJ, Al-Rejaie SS, Abuohashish HM, Al-Assaf A, Parmar MY, Ola MS, et al. Neuroprotective effects of Gymnema sylvestre on streptozotocin-induced diabetic neuropathy in rats. Exp Ther Med. 2015;9:1670\u20138. https:\/\/doi.org\/10.3892\/etm.2015.2305.","journal-title":"Exp Ther Med"},{"key":"3949_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/s2175-97902020000118501","author":"J Archana","year":"2022","unstructured":"Archana J, Annapurna A, Devayani P. Neuroprotective role of Tinospora cordifolia extract in streptozotocin-induced neuropathic pain. Braz J Pharm Sci. 2022. https:\/\/doi.org\/10.1590\/s2175-97902020000118501.","journal-title":"Braz J Pharm Sci"},{"key":"3949_CR34","unstructured":"Genedy D, FAEAHH, FSEA. Potential neuroprotective effect of trimetazidine and metformin on autophagy in a rat model of diabetic peripheral neuropathy: role of LC3 and P62. J Pop Ther Clin Pharmacol. 2022;29."},{"key":"3949_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.22037\/ijpr.2020.1101144","volume":"19","author":"F Ramezani-Aliakbari","year":"2020","unstructured":"Ramezani-Aliakbari F, Badavi M, Dianat M, Mard SA, Ahangarpour A. Trimetazidine increases plasma MicroRNA-24 and MicroRNA-126 levels and improves dyslipidemia, inflammation and hypotension in diabetic rats. Iran J Pharm Res. 2020;19:248\u201357. https:\/\/doi.org\/10.22037\/ijpr.2020.1101144.","journal-title":"Iran J Pharm Res"},{"key":"3949_CR36","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.toxlet.2015.01.010","volume":"233","author":"T Liang","year":"2015","unstructured":"Liang T, Zhang Q, Sun W, Xin Y, Zhang Z, Tan Y, et al. Zinc treatment prevents type 1 diabetes-induced hepatic oxidative damage, endoplasmic reticulum stress, and cell death, and even prevents possible steatohepatitis in the OVE26 mouse model: important role of metallothionein. Toxicol Lett. 2015;233:114\u201324. https:\/\/doi.org\/10.1016\/j.toxlet.2015.01.010.","journal-title":"Toxicol Lett"},{"key":"3949_CR37","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s40618-016-0514-9","volume":"39","author":"IM Talaat","year":"2016","unstructured":"Talaat IM, Nasr A, Alsulaimani AA, Alghamdi H, Alswat KA, Almalki DM, et al. Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes. J Endocrinol Invest. 2016;39:1425\u201334. https:\/\/doi.org\/10.1007\/s40618-016-0514-9.","journal-title":"J Endocrinol Invest"},{"key":"3949_CR38","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1159\/000478761","volume":"42","author":"RM Gomes","year":"2017","unstructured":"Gomes RM, de Paulo LF, Bonato Panizzon CPdoN, Neves CQ, Cordeiro BC, Zanoni JN, et al. Anti-diabetic effects of the ethyl-acetate fraction of Trichilia catigua in streptozotocin-induced type 1 diabetic rats. Cell Physiol Biochem. 2017;42:1087\u201397. https:\/\/doi.org\/10.1159\/000478761.","journal-title":"Cell Physiol Biochem"},{"key":"3949_CR39","doi-asserted-by":"crossref","unstructured":"Al-Metwaly AA, SGS, SAM, SGM. Protective effects of trimetazidine against acetaminophen-induced liver injury in mice. J Pharm Sci Pharmacol. 2017;3, 34\u201334.","DOI":"10.1166\/jpsp.2017.1074"},{"key":"3949_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/7674366","volume":"2022","author":"X Tang","year":"2022","unstructured":"Tang X, Gong J. Assessment of trimetazidine treatment in acute myocardial infarction patients undergoing percutaneous coronary intervention. Cardiol Res Pract. 2022;2022:1\u20138. https:\/\/doi.org\/10.1155\/2022\/7674366.","journal-title":"Cardiol Res Pract"},{"key":"3949_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.645041","author":"X Luo","year":"2021","unstructured":"Luo X, Zhong Z, Chong A, Zhang W, Wu X. Function and mechanism of trimetazidine in myocardial infarction-induced myocardial energy metabolism disorder through the SIRT1\u2013AMPK pathway. Front Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.645041.","journal-title":"Front Physiol"},{"key":"3949_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.735165","author":"MY Al-Shorbagy","year":"2021","unstructured":"Al-Shorbagy MY, Wadie W, El-Tanbouly DM. Trimetazidine modulates mitochondrial redox status and disrupted glutamate homeostasis in a rat model of epilepsy. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.735165.","journal-title":"Front Pharmacol"},{"key":"3949_CR43","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10715762.2014.999674","volume":"49","author":"R Afrin","year":"2015","unstructured":"Afrin R, Arumugam S, Soetikno V, Thandavarayan RA, Pitchaimani V, Karuppagounder V, et al. Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats. Free Radic Res. 2015;49:279\u201389. https:\/\/doi.org\/10.3109\/10715762.2014.999674.","journal-title":"Free Radic Res"},{"key":"3949_CR44","first-page":"3","volume":"80","author":"HH Mutlu","year":"2017","unstructured":"Mutlu HH, Caklili OT, Coskunpinar E. Serum concentrations of cyclophilin A in patients with nonalcoholic fatty liver disease. Acta Gastroenterol Belg. 2017;80:3\u20137.","journal-title":"Acta Gastroenterol Belg"},{"key":"3949_CR45","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.biopha.2017.09.104","volume":"95","author":"J Wang","year":"2017","unstructured":"Wang J, Wang C, Li S, Li W, Yuan G, Pan Y, et al. Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway. Biomed Pharmacother. 2017;95:1669\u201377. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.104.","journal-title":"Biomed Pharmacother"},{"key":"3949_CR46","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.3390\/ijms13055751","volume":"13","author":"H Raza","year":"2012","unstructured":"Raza H, John A. Streptozotocin-induced cytotoxicity, oxidative stress and mitochondrial dysfunction in human hepatoma HepG2 cells. Int J Mol Sci. 2012;13:5751\u201367. https:\/\/doi.org\/10.3390\/ijms13055751.","journal-title":"Int J Mol Sci"},{"key":"3949_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/740671","volume":"2012","author":"AA Abolfathi","year":"2012","unstructured":"Abolfathi AA, Mohajeri D, Rezaie A, Nazeri M. Protective effects of green tea extract against hepatic tissue injury in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med. 2012;2012:1\u201310. https:\/\/doi.org\/10.1155\/2012\/740671.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3949_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1515\/jcim-2021-0142","volume":"19","author":"S Niazmand","year":"2022","unstructured":"Niazmand S, Mirzaei M, Hosseinian S, Khazdair MR, Gowhari Shabgah A, Baghcheghi Y, et al. The effect of Cinnamomum cassia extract on oxidative stress in the liver and kidney of STZ-induced diabetic rats. J Complement Integr Med. 2022;19:311\u201321. https:\/\/doi.org\/10.1515\/jcim-2021-0142.","journal-title":"J Complement Integr Med"},{"key":"3949_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.crphar.2024.100201","volume":"7","author":"G Firouzeh","year":"2024","unstructured":"Firouzeh G, Susan A, Zeinab K. Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-\ua7b5\/apelin gene expression. Curr Res Pharmacol Drug Discov. 2024;7:100201. https:\/\/doi.org\/10.1016\/j.crphar.2024.100201.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"3949_CR50","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","volume":"59","author":"S Sutti","year":"2014","unstructured":"Sutti S, Jindal A, Locatelli I, Vacchiano M, Gigliotti L, Bozzola C, et al. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. Hepatology. 2014;59:886\u201397. https:\/\/doi.org\/10.1002\/hep.26749.","journal-title":"Hepatology"},{"key":"3949_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091051","volume":"14","author":"G Demiral","year":"2024","unstructured":"Demiral G, Mercantepe T, Altuntas G, Pergel A, Kalcan S, Ozdemir A, et al. Evaluation of endoplasmic reticulum stress in an experimental intestinal ischemia\u2013reperfusion model in rats: the role of ozone therapy and trimetazidine. Biomolecules. 2024;14:1051. https:\/\/doi.org\/10.3390\/biom14091051.","journal-title":"Biomolecules"},{"key":"3949_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000180","volume":"23","author":"CA D\u00e9zsi","year":"2016","unstructured":"D\u00e9zsi CA. Trimetazidine in practice. Am J Ther. 2016;23:e871\u2013e879. https:\/\/doi.org\/10.1097\/MJT.0000000000000180.","journal-title":"Am J Ther"},{"key":"3949_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0891-5849(99)00197-5","volume":"28","author":"S Brunet","year":"2000","unstructured":"Brunet S, Thibault L, Lepage G, Seidman EG, Dub\u00e9 N, Levy E. Modulation of endoplasmic reticulum-bound cholesterol regulatory enzymes by iron\/ascorbate-mediated lipid peroxidation. Free Radic Biol Med. 2000;28:46\u201354. https:\/\/doi.org\/10.1016\/S0891-5849(99)00197-5.","journal-title":"Free Radic Biol Med"},{"key":"3949_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-19-71","volume":"19","author":"A Mahfoudh-Boussaid","year":"2012","unstructured":"Mahfoudh-Boussaid A, Zaouali MA, Hauet T, Hadj-Ayed K, Miled A-H, Ghoul-Mazgar S, et al. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J Biomed Sci. 2012;19:71. https:\/\/doi.org\/10.1186\/1423-0127-19-71.","journal-title":"J Biomed Sci"},{"key":"3949_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136115","volume":"761","author":"Y Dai","year":"2021","unstructured":"Dai Y, Ba X. Effects of exogenous vitamin D on endoplasmic reticulum stress-related factors in the vitamin D deficiency rats with cerebral ischemia. Neurosci Lett. 2021;761:136115. https:\/\/doi.org\/10.1016\/j.neulet.2021.136115.","journal-title":"Neurosci Lett"},{"key":"3949_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109959","volume":"117","author":"S Zhang","year":"2023","unstructured":"Zhang S, Tang J, Sun C, Zhang N, Ning X, Li X, et al. Dexmedetomidine attenuates hepatic ischemia-reperfusion injury-induced apoptosis via reducing oxidative stress and endoplasmic reticulum stress. Int Immunopharmacol. 2023;117:109959. https:\/\/doi.org\/10.1016\/j.intimp.2023.109959.","journal-title":"Int Immunopharmacol"},{"key":"3949_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/2212697X08666211006100250","volume":"8","author":"OH Minchenko","year":"2021","unstructured":"Minchenko OH, Tsymbal DO, Khita OO, Minchenko DO. Inhibition of ERN1 signaling is important for the suppression of tumor growth. Clinical Cancer Drugs. 2021;8:27\u201338. https:\/\/doi.org\/10.2174\/2212697X08666211006100250.","journal-title":"Clinical Cancer Drugs"},{"key":"3949_CR58","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10645","author":"X Chi","year":"2019","unstructured":"Chi X, Jiang Y, Chen Y, Yang F, Cai Q, Pan F, et al. Suppression of microrna-27a protects against liver ischemia\/reperfusion injury by targeting PPAR\u03b3 and inhibiting endoplasmic reticulum stress. Mol Med Rep. 2019. https:\/\/doi.org\/10.3892\/mmr.2019.10645.","journal-title":"Mol Med Rep"},{"key":"3949_CR59","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/1753425913508593","volume":"20","author":"S Kim","year":"2014","unstructured":"Kim S, Joe Y, Jeong SO, Zheng M, Back SH, Park SW, et al. Endoplasmic reticulum stress is sufficient for the induction of IL-1\u03b2 production via activation of the NF-\u03baB and inflammasome pathways. Innate Immun. 2014;20:799\u2013815. https:\/\/doi.org\/10.1177\/1753425913508593.","journal-title":"Innate Immun"},{"key":"3949_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413228","volume":"22","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ding S. NLRP3 inflammasome in diabetic cardiomyopathy and exercise intervention. Int J Mol Sci. 2021;22:13228. https:\/\/doi.org\/10.3390\/ijms222413228.","journal-title":"Int J Mol Sci"},{"key":"3949_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00114","author":"A Sharma","year":"2018","unstructured":"Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 2018. https:\/\/doi.org\/10.3389\/fphys.2018.00114.","journal-title":"Front Physiol"},{"key":"3949_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6305735","author":"W Leng","year":"2016","unstructured":"Leng W, Ouyang X, Lei X, Wu M, Chen L, Wu Q, et al. The SGLT-2 inhibitor dapagliflozin has a therapeutic effect on atherosclerosis in diabetic ApoE \u2212\/\u2212 mice. Mediators Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/6305735.","journal-title":"Mediators Inflamm"},{"key":"3949_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9743280","author":"Z Qiu","year":"2017","unstructured":"Qiu Z, Lei S, Zhao B, Wu Y, Su W, Liu M, et al. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia\/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017. https:\/\/doi.org\/10.1155\/2017\/9743280.","journal-title":"Oxid Med Cell Longev"},{"key":"3949_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214471","volume":"23","author":"CY-J Kuo","year":"2022","unstructured":"Kuo CY-J, Maran JJ, Jamieson EG, Rupenthal ID, Murphy R, Mugisho OO. Characterization of NLRP3 inflammasome activation in the onset of diabetic retinopathy. Int J Mol Sci. 2022;23:14471. https:\/\/doi.org\/10.3390\/ijms232214471.","journal-title":"Int J Mol Sci"},{"key":"3949_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114634","volume":"190","author":"PJ Hohensinner","year":"2021","unstructured":"Hohensinner PJ, Lenz M, Haider P, Mayer J, Richter M, Kaun C, et al. Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation. Biochem Pharmacol. 2021;190:114634. https:\/\/doi.org\/10.1016\/j.bcp.2021.114634.","journal-title":"Biochem Pharmacol"},{"key":"3949_CR66","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00011-021-01530-6","volume":"71","author":"X Chen","year":"2022","unstructured":"Chen X, Lin S, Dai S, Han J, Shan P, Wang W, et al. Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia\/reperfusion injury. Inflamm Res. 2022;71:227\u201341. https:\/\/doi.org\/10.1007\/s00011-021-01530-6.","journal-title":"Inflamm Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03949-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03949-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03949-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:29:24Z","timestamp":1775035764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03949-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03949-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}